BR0209613A - Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro - Google Patents
Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiroInfo
- Publication number
- BR0209613A BR0209613A BR0209613-7A BR0209613A BR0209613A BR 0209613 A BR0209613 A BR 0209613A BR 0209613 A BR0209613 A BR 0209613A BR 0209613 A BR0209613 A BR 0209613A
- Authority
- BR
- Brazil
- Prior art keywords
- eliminating
- reducing
- composition
- likelihood
- addiction
- Prior art date
Links
- 206010012335 Dependence Diseases 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 abstract 4
- 239000003445 gaba agent Substances 0.000 abstract 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO PARA TRATAMENTO DE DOR EM UM MAMìFERO, E, MéTODO PARA REDUçãO OU ELIMINAçãO DE PROBABILIDADE DE VICIAMENTO DE UM ANALGéSICO EM UM HOSPEDEIRO". A presente invenção provê uma composição para tratamento da dor. A composição inclui um analgésico farmaceuticamente aceitável e um agente GABAérgico, como gama vinil GABA, eficaz em reduzir ou eliminar a probabilidade de viciamento do analgésico. A invenção também inclui um método para reduzir ou eliminar a probabilidade de viciamento de um analgésico por administração de um agente GABAérgico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/853,548 US20020187996A1 (en) | 2001-05-14 | 2001-05-14 | Prevention of addiction in pain management |
PCT/US2002/011072 WO2002091990A2 (en) | 2001-05-14 | 2002-04-08 | Prevention of addiction in pain management |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0209613A true BR0209613A (pt) | 2004-12-07 |
Family
ID=25316324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0209613-7A BR0209613A (pt) | 2001-05-14 | 2002-04-08 | Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro |
Country Status (21)
Country | Link |
---|---|
US (3) | US20020187996A1 (pt) |
EP (1) | EP1392301B1 (pt) |
JP (1) | JP2004534029A (pt) |
KR (1) | KR20040020054A (pt) |
CN (1) | CN100528156C (pt) |
AT (1) | ATE473001T1 (pt) |
AU (1) | AU2002342533B2 (pt) |
BR (1) | BR0209613A (pt) |
CA (1) | CA2446639C (pt) |
CZ (1) | CZ20033380A3 (pt) |
DE (1) | DE60236927D1 (pt) |
ES (1) | ES2348637T3 (pt) |
HR (1) | HRP20030892A2 (pt) |
HU (1) | HUP0402326A3 (pt) |
IL (1) | IL158762A0 (pt) |
MX (1) | MXPA03010407A (pt) |
NO (1) | NO331509B1 (pt) |
NZ (1) | NZ529614A (pt) |
PL (1) | PL368505A1 (pt) |
WO (1) | WO2002091990A2 (pt) |
YU (1) | YU89003A (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080053423A (ko) * | 2000-07-31 | 2008-06-12 | 니코메드 댄마크 에이에스 | 코 투여용 펜타닐 조성물 |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
US20050043345A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
CN105497896A (zh) * | 2015-03-31 | 2016-04-20 | 苏州大学 | 一种肿瘤耐药的靶点及其应用 |
KR20230117591A (ko) | 2020-12-04 | 2023-08-08 | 라보라토리오스 실레인즈, 에스.에이. 드 씨.브이. | 통증 경감을 위한 오피오이드 진통제 및 항경련제를함유하는 안정한 코팅된, 고형의 약학적 조성물 |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057368A (en) * | 1998-08-05 | 2000-05-02 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
US6541520B1 (en) * | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
-
2001
- 2001-05-14 US US09/853,548 patent/US20020187996A1/en not_active Abandoned
-
2002
- 2002-04-08 BR BR0209613-7A patent/BR0209613A/pt not_active IP Right Cessation
- 2002-04-08 ES ES02769652T patent/ES2348637T3/es not_active Expired - Lifetime
- 2002-04-08 JP JP2002588909A patent/JP2004534029A/ja active Pending
- 2002-04-08 IL IL15876202A patent/IL158762A0/xx unknown
- 2002-04-08 EP EP02769652A patent/EP1392301B1/en not_active Expired - Lifetime
- 2002-04-08 DE DE60236927T patent/DE60236927D1/de not_active Expired - Lifetime
- 2002-04-08 YU YU89003A patent/YU89003A/sh unknown
- 2002-04-08 NZ NZ529614A patent/NZ529614A/en unknown
- 2002-04-08 KR KR10-2003-7014736A patent/KR20040020054A/ko not_active Application Discontinuation
- 2002-04-08 PL PL02368505A patent/PL368505A1/xx not_active Application Discontinuation
- 2002-04-08 CN CNB028098277A patent/CN100528156C/zh not_active Expired - Fee Related
- 2002-04-08 CA CA2446639A patent/CA2446639C/en not_active Expired - Fee Related
- 2002-04-08 AT AT02769652T patent/ATE473001T1/de not_active IP Right Cessation
- 2002-04-08 WO PCT/US2002/011072 patent/WO2002091990A2/en active IP Right Grant
- 2002-04-08 MX MXPA03010407A patent/MXPA03010407A/es not_active Application Discontinuation
- 2002-04-08 AU AU2002342533A patent/AU2002342533B2/en not_active Ceased
- 2002-04-08 CZ CZ20033380A patent/CZ20033380A3/cs unknown
- 2002-04-08 HU HU0402326A patent/HUP0402326A3/hu unknown
- 2002-04-18 US US10/124,660 patent/US6939876B2/en not_active Expired - Fee Related
-
2003
- 2003-01-02 US US10/335,800 patent/US20030134868A1/en not_active Abandoned
- 2003-11-05 HR HR20030892A patent/HRP20030892A2/xx not_active Application Discontinuation
- 2003-11-13 NO NO20035038A patent/NO331509B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2002342533B2 (en) | 2007-07-05 |
WO2002091990A3 (en) | 2003-03-27 |
CN100528156C (zh) | 2009-08-19 |
WO2002091990A2 (en) | 2002-11-21 |
US20030134868A1 (en) | 2003-07-17 |
ATE473001T1 (de) | 2010-07-15 |
CZ20033380A3 (cs) | 2005-03-16 |
NZ529614A (en) | 2006-08-31 |
CA2446639C (en) | 2010-11-02 |
US20030004176A1 (en) | 2003-01-02 |
CN1531431A (zh) | 2004-09-22 |
JP2004534029A (ja) | 2004-11-11 |
HUP0402326A2 (hu) | 2005-02-28 |
KR20040020054A (ko) | 2004-03-06 |
EP1392301B1 (en) | 2010-07-07 |
HUP0402326A3 (en) | 2008-04-28 |
NO20035038D0 (no) | 2003-11-13 |
EP1392301A4 (en) | 2004-07-14 |
IL158762A0 (en) | 2004-05-12 |
DE60236927D1 (de) | 2010-08-19 |
MXPA03010407A (es) | 2004-05-05 |
US20020187996A1 (en) | 2002-12-12 |
EP1392301A2 (en) | 2004-03-03 |
YU89003A (sh) | 2006-08-17 |
CA2446639A1 (en) | 2002-11-21 |
US6939876B2 (en) | 2005-09-06 |
ES2348637T3 (es) | 2010-12-10 |
HRP20030892A2 (en) | 2005-08-31 |
NO331509B1 (no) | 2012-01-16 |
PL368505A1 (en) | 2005-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005074913A3 (en) | Compositions and methods for treating contracture | |
AR027234A1 (es) | Derivados de la toxina clostridial y metodos para el tratamiento del dolor | |
AR049955A1 (es) | Composiciones y metodos para el tratamiento de trastornos metabolicos | |
BR0212019A (pt) | Formas de dosagem, métodos para o tratamento da dor, métodos de preparação de uma forma de dosagem e métodos para impedir o abuso de uma forma de dosagem | |
AU2003268144A1 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
BRPI0508769A (pt) | forma de dosagem resistente a adulteração compreendendo um adsorvente e um agente adverso | |
BR0306919A (pt) | Métodos para reduzir ou suprimir a efetividade adversa da terapia de l-dopa e/ou do agonista da dopamina, e para tratamento moderado de l-dopa, composição para tratamento moderado de l-dopa, método para tratar doença de parkinson e/ou complicações motoras de l-dopa, composição para o tratamento da doença de parkinson, e, métodos para prolongar o tratamento eficaz da doença de parkinson, e para tratar os distúrbios de movimento | |
IS8187A (is) | Meðferð á fráhvarfseinkennum | |
TWI367751B (en) | Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction | |
BR0200246A (pt) | Tratamento de combinação para a depressão | |
BR0315573A (pt) | Método para tratar, prevenir, controlar e/ou modificar dor em um paciente e composição farmacêutica | |
WO2006002096A3 (en) | Low doses of l-citrulline for treating diseases | |
HRP20080146T3 (en) | Preoperative treatment of post operative pain | |
ATE531366T1 (de) | Zusammensetzungen und verfahren zur behandlung, verminderung, verbesserung oder linderung von erkrankungen des hinteren augensegments | |
BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão | |
BR0209613A (pt) | Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro | |
BR0311903A (pt) | Tratamento para depressão e ansiedade pela combinação de um inibidor de pde iv e um agente antidepressivo ou ansiolìtico | |
BR0201974A (pt) | Composição farmacêutica para tratamento de alterações do sono | |
BR0211855A (pt) | Medicamento e método para tratamento e melhoria da qualidade restauradora do sono | |
BR0307022A (pt) | Método de tratamento de um paciente que precisa de analgesia | |
BR0315609A (pt) | Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica | |
BR0111900A (pt) | Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca | |
WO2003103675A3 (en) | COMBINATION THERAPIES FOR PURINOCEPTOR RELATED DISORDERS | |
WO2023079466A3 (en) | Treatment of sequelae of coronavirus infections | |
TNSN03022A1 (en) | Method for treatment of inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUI DADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 10A ANUIDADE. |